Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

published as open access, Authors retain copyright but licence exclusive rights in their article to the publisher. Authors have the right to:

● Share their article in the same ways permitted to third parties under the relevant user licence (together with personal (scholarly) purposes to create certain derivative works), as long as they give proper attribution and credit to the published work.
● Retain patent, trademark and other intellectual property rights (including raw research data).
● Proper attribution and credit for the published work
Open Access Policy

Creative Commons Attribution-NonCommercial(CC BY-NC):

Allows users to copy and distribute the Article, provided this is not done for commercial purposes and further does not permit distribution of the Article if it is changed or edited in any way, and provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, and that the licensor is not represented as endorsing the use made of the work. The full details of the license are available at https://creativecommons.org/licenses/by-nc/4.0/.

Copyediting and Proofs

Manuscripts must be written either in good American or British English, in a clear language, correct punctuations, and consistent style throughout the manuscript. Authors are advised to send for professional English language editing service before submission. (Viser Manuscript Submission Template)

Editorial Policies

Peer Review

Viser Technology Pte. Ltd. follows a double-blind peer-review procedure for submissions of all manuscripts to its journals.

All submitted manuscripts are subjected to a fair, unbiased, and extensive peer review in consultation with the assigned journal's Editorial Board Member and independent internal or external referees (usually two reviewers), which have expertise in the field of the submitted manuscripts. The peer-review applies a short and rapid, but fair and professional assessment on all submitted manuscripts. The journal's Editor-in-Chief is then decided on the submitted manuscripts based on all the peer reviewers' comments before conveying to the author(s).

All submissions from the Editor-in-Chief will undergo independent peer-review and assess by the journal's Editorial Board Member or in-house Editor for the decision on acceptance.

Ethical Approval of Studies and Informed Consent

For human or animal experimental investigations, it is a prerequisite to provide a formal review and approval, or review and waiver, by an appropriate institutional review board or ethics committee, which should be documented in the paper. For investigations undertaken on human subjects, the manner in which the informed consent was obtained from the study participants (i.e., oral or written) should be stated clearly in the Materials and Methods section.

The authors must obtain patient consent either orally or written when they use confidential case material. However, patient consent is not required for very brief case vignettes that do not contain identifying information or if the case material is masked sufficiently to prevent the identification of the patient.

The authors should inform and discuss with the recruiting patients on the purpose(s) of publication, the possible risks and benefits to obtain, and the patient's right to withhold or withdraw consent. In the case of a minor patient, consent should be obtained from the parent(s) or guardian(s). The authors should not perform any misconduct or deceive the recruiting patients in obtaining their consent.

Standard Protocol on Approvals, Registrations, Patients Consents & Animal Protection

Human: All clinical investigations must be conducted according to the Declaration of Helsinki principles, as revised in 2000 and 2008. Authors must comply with the guidelines of the International Committee of Medical Journal Editors (www.icmje.org) in conjunction with the patient's consent for research or participation in a study. Patients' names, initials, or hospital numbers must not be mentioned anywhere in the manuscript (including figures). Editors may request the authors to provide documentation of the formal review and recommendation from the institutional review board or ethics committee responsible for oversight of the study if necessary.

Animals: All original research manuscripts involving the use of animals, the authors should indicate whether relevant international, national, and/or institutional guidelines for the care and use of laboratory animals were conducted accordingly. The authors must include details of animal welfare (such as species, number, gender, age, weight, housing conditions, welfare, training and the fate of the animals at the end of the experiment) and relevant details of steps taken to ameliorate suffering in all works in the Materials and Method section of a manuscript. Similarly, any experiments involving animals from clients or private institutions, the authors are required to get informed client consent and adhere to a high standard (best practice) of veterinary care. These details should be included in the Materials and Methods section of the manuscript.

Publishing Ethics

Publishing Policies

Viser Technology Pte. Ltd. requests all members involved in the journal publishing process to adhere to the "Code of Conduct for Journal Editors" and "Code of Conduct for Journal Publishers" as stipulated by COPE (Committee on Publication Ethics).

The publisher strictly adheres to the guidelines and best practices, which include Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from the International Committee of Medical JournalsEditors (ICMJE) and the Principles of Transparency and Best Practice in Scholarly Publishing developed by Committee on Publication Ethics (COPE), Directory of Open Access Journals (DOAJ), Open Access Scholarly Publishers Association (OASPA) and World Association of Medical Editors (WAME).

PUBLICATIONS ETHICS AND MALPRACTICE STATEMENT
Home Information Publications Ethics and Malpractice Statement
As a prestigious peer-reviewed journal we emphasize on publications ethics for editors, reviewers, authors, and publisher very much. We mainly follow the existing SCOPUS requirements and the Committee on Publication Ethics (COPE) Code of Conduct which are widely recognized in the world.

Peer-reviewed articles support and embody the scientific method. It is therefore important to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editor, the peer reviewer, and the society of TIIS.

PUBLICATION AND AUTHORSHIP
An authorship is generally considered to be an individual who has made substantial intellectual contributions to a publication (or an article).

Additional criteria for authorship include the following:
- Substantial contributions to the conception or design of the work or the acquisition, analysis, or interpretation of data for the work
- Drafting the work or revising it critically for important Intellectual content
- Final approval of the version to be published
- Agreement to be accountable for all aspects of the work in ensuring that questions related th the accuracy or integrity of any part of the work are appropriately investigated and resolved
All articles should be original and not published in any other journals before. If an author is using a lengthy text from another source, it should be cited within quotes and the reference should be given properly. Plagiarism or self-plagiarism in any form will never be acceptable.
An article should acknowledge and cite the work of others where appropriate, fully and accurately attributing relevant sources. In general, the article provides a list of references.
The article may acknowledge the funding, support, sponsorship and other forms of input (including that of the university, institute, organization or government) to the work in an appropriate way.
The prospective author must make sure that the submitted article is not under publication consideration or under review in another journal. We will not accept any articles with same exact material from another journal.
If the submitted article is an extended version of the article already presented in a conference, the author should address it in front page of the submitted paper and in addition, the author must submit the preliminary article published in the conference proceedings too. Unless the preliminary article is submitted, We will not accept submission for review. The extended version of the submitted article should add more than 30% substantial contents compared to the preliminary article.

AUTHOR'S RESPONSIBILITIES
All authors should agree to make plausible revisions to be suggested by reviewers and the editorial members . If the author refuses to do the revision without acceptable causes, the submitted article will be immediately rejected.
All authors will be required to correct any errors and to withdraw incorrect information in the submitted article.
All authors who have made a significant contribution to the article should be included as co-authors. An inclusion of person(s) who do not contribute in the co-author list is inappropriate. One of co-authors should sign a copyright transfer form before the final publication.

PEER REVIEW/RESPONSIBILITY FOR THE REVIEWERS
All of the submitted papers will be peer-reviewed. The name of all reviewers will be blind. All reviewers should be academically qualified to review a submitted article, and they should complete her/his review scores and review comments in time. The review comments will be constructive for authors.
The reviewer should be fair and unprejudiced in reviewing a submitted article.
The reviewer should not have any conflict of interest with the research, author, or the research funding authorities of a submitted article. In case of a conflicting interest, the reviewer should inform the assigned editor of it and the assigned editor will manage the conflict by reassigning required reviewer(s) to the article.
The reviewer should not reveal any information related to the assigned article to other parties.

EDITORIAL RESPONSIBILITIES
The Editor-in-Chief and editor should preclude business needs from compromising intellectual standards.
The EIC and editor should ensure the quality of the material they publish.
The EIC has the authority to make a final decision on the submitted article based on reviewers' and editor's review scores/comments or his/her own discretion.
The editor can make a preliminary decision on the submitted paper based on reviewers' scores/comments or his/her own discretion. The editor can provide his/her own review comments or suggestions on the submitted paper with EIC.
The EIC and editor should be fair and should not use prejudice/bias of any kind against the author during the review process.
The EIC and editor's decisions to accept or reject a paper for publication should be based only on the paper's importance, originality, and clarity, and the study's relevance to the remit of the journal.
The EIC or any member of the editorial board should not have any conflict of interest regarding the article under consideration.
Anonymity of reviewers as well as the author should be maintained by the EIC and editor during the review process.
When an error is found, the EIC should correct it immediately or withdraw the publication.

PUBLISHING ETHICS ISSUES
Monitoring/safeguarding of the publishing ethics will be maintained by the EIC and the editorial board.
The EIC with the editorial board should maintain high levels of intellectual and ethical standards, precluding business needs from compromising intellectual standards.
The EIC should ensure that plagiarism, self-plagiarism, and fraudulent data are not allowed as mentioned above.
The EIC should be willing to publish corrections, clarifications, withdrawals, and apologies as appropriate when needed.

期刊以“平面媒体+网络传播”方式互动，内容聚焦智能城市建设，解读行业政策，传播行业技术标准；组建权威的业内专家团队，为期刊提供精粹的观点、尖端技术解读；以科技成果传播为核心，关注自主创新，宣传展示各地智能城市建设成就；剖析各领域典型应用案例，分享最新技术理论与产品，全方位深度覆盖诸多物联网与智能城市应用领域，为相关信息化管理部门及广大设计院、系统集成商、建筑工程公司、房地产开发商、物业管理公司、产品生产厂商等相关单位提供各类参考资料。

鼓励智能城市建设领域的专业技术人员和管理干部以及大专院校相关专业的师生和科研人员来稿，有关国家科技计划、自然科学基金和各种部门、地方、院所科技基金资助项目的文章优先发布。

ISSN: 2630-5305 (online)

ISSN: 2717-5391 (print)

The publication frequency of this journal is Monthly

• CrossRef
• CNKI

• China Science and Technology Journal Database

Email: smart_city_appl@outlook.com

This journal charges an article processing charge of S$ 600.00 (Singapore Dollars)

Viser Technology provides the following payment channels. Upon reception of the invoice from Viser, you may choose one of the following payment methods that suit you the most.

Bank Transfer / Wire Transfer

• Bank: DBS Bank Ltd
• Account Name: Viser Technology Pte Ltd
• Account No.: 023-906417-5
• Swift Code: DBSSSGSG

Alipay / Wechat Pay

Scan the following QR code for payment

UnionPay

Viser supports payments via UnionPay. If you wish to make the payment using a UnionPay enabled credit/debit card, please contact us at viser-tech@outlook.com to request for the payment link to be sent to your email address. Once you have received the payment request email, click on the link to go to the secure UnionPay payment page to complete the payment.

In your payment request email, please indicate the following information:

• Author Name(s)
• Article Number
• Article Title
• Journal Title

Should you encounter any problem related to payment, please contact viser-tech@outlook.com for assistance.

The 2019 World Transport Convention (WTC) is jointly sponsored by China Association for Science and Technology, Ministry of Transport and Chinese Academy of Engineering and China Highway and Transportation Society.Viser Technology is the media support unit and publish thematic special issues.T…

经国务院批准，由中国科学技术协会、交通运输部、中国工程院共同主办，中国公路学会承办，国内外交通运输科研机构、院校、企事业单位和社会组织的共同支持的2019世界交通运输大会，定于2019年6月13日至16日在北京国家会议中心举行。6月13日报到，6月14日-16日开会。大会以“智能绿色引领未来交通”为主题，内容涵盖学术交流、成果推广、产品展示、国际合作、科技竞赛、学科报告与标准发布等内容，旨在为世界交通运输行业提供酝酿创新、主导创新、展示创新和实施创新的国际化交流平台。

会议时间：
2019年6月13日至16日
6月13日：代表报到及闭门会议；
6月14日至16日：大会开幕…